Relationship between Corrected-QT Intervals and Other ECG Characteristics with Methadone Dose in Methadone Maintenance Treatment (MMT) Patients and Healthy Subjects: A Case- Control Study

Razavi International Journal of Medicine. 2017;5(2) DOI 10.5812/rijm.13642

 

Journal Homepage

Journal Title: Razavi International Journal of Medicine

ISSN: 2345-6426 (Print); 2345-6434 (Online)

Publisher:  Razavi Hospital, Mashhad, Iran

LCC Subject Category: Medicine

Country of publisher: Iran, Islamic Republic of

Language of fulltext: English

Full-text formats available: PDF, HTML

 

AUTHORS

Mina Akbari Rad (School of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran)
Abdollah Firoozi (School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, IR Iran)
Fatemeh Akbarirad (School of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran)
Mahdi Hassanzade Daloee (Cardiovascular Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran)
Shokoofeh Bonakdaran (Endocrinology Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran)

EDITORIAL INFORMATION

Peer review

Editorial Board

Instructions for authors

Time From Submission to Publication: 20 weeks

 

Abstract | Full Text

Background In this study we assessed the relationship between corrected-QT intervals and other ECG characteristics with methadone dose and other parameters in MMT patients and healthy subjects. Methods This was a case-control study which was carried out on patients underwent MMT and healthy control group who had been referred to Ebne-Sina academic hospital, Mashhad during 2014 - 2015. At the time of the study, 40 patients who received MMT therapy for at least 6 months and 40 voluntary healthy subjects who matched on age and sex enrolled in the study. 12-lead ECG was performed for all the patients. Mean QT interval, PR interval and QRS duration in every 12 leads were documented for each patient in maximum. Results To evaluate the patients, we divided 80 patients into two groups: 40 patients under treatment with Methadone and 40 voluntary participants as control group. There were 20 males and 20 females in each group. Duration of addiction was 214.80 ± 126.99 months in MMT group. Significant differences were observed in PRi between the patient and control groups (P = 0.007), and also between methadone dose and PRi (r = 0.468, P = 0.038) in males. QTc prolongation was reported in 4 patients of addicted group (10%). All of the QTc prolongation patients were female (P = 0.037). There was significant relationship between PRi and weight (P = 0.015), addiction period (P = 0.011), methadone treatment period (P = 0.018) as well as methadone dosage (P = 0.14). Methadone cut off point of 65 mg had a significant relationship with systolic blood pressure (P = 0.002), diastolic blood pressure (P = 0.013), QTCi (P = 0.016) and QRS (P = 0.044); however, no significant relationship was reported with PRi (P = 0.451). Conclusions We found that there is no exact dosage of methadone in which the side effects such as TdP (Torsade de pointes) or QTc prolongation can be predicted. Female gender and methadone dosage ≥ 65 mg were risk factors of our study for QTc prolongation which may result in subsequent deteriorated conditions.